Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Linezolid was provided for treatment of multidrug-resistant, gram-positive infections through a compassionate-use program. Patients (n=796) received 600 mg of linezolid intravenously or orally every 12 h (828 treatment courses). Bacteremia was present in 46% of infections, endocarditis was present in 10.6%, and line-related infections were present in 31.1%. Other infections included intraabdominal infections (15.1%), complicated skin and skin-structure infections (13.3%), and osteomyelitis (10.7%). Causative pathogens included vancomycin-resistant enterococci (66.3%) and methicillin-resistant staphylococci (22.1%). Clinical intent-to-treat (ITT) outcomes in the evaluable population were as follows: cure, 73.3%; failure, 6.8%; and indeterminate, 19.9%. Microbiological ITT outcomes in evaluable patients were as follows: cure, 82.4%; failure, 14.1%; and indeterminate, 3.5%. At the test of cure assessment, the clinical cure and microbiological success rates were 91.5% and 85.8%, respectively. The most common adverse events possibly related to linezolid use were gastrointestinal disturbances (9.8% of cases), thrombocytopenia (7.4% of cases), decreased hemoglobin/hematocrit levels (4.1% of cases), and cutaneous reactions (4.0% of cases). Linezolid provided high rates of clinical cure and microbiological success in this complicated patient population, with very good overall tolerance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Birmingham et al 202 reported cure in 17 of 22 courses of therapy (77%) for E faecium IE.”
Citations
Cites
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
Stevens, D. L., Herr, D., Lampiris, H., Hunt, J. L., Batts, D. H., Hafkin, B., & the Linezolid MRSA Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/340353 · Cited by 506
Self-citationIn vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E., Hutchinson, D. K., Barbachyn, M. R., & Brickner, S. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.839 · Cited by 461
Hematologic Effects of Linezolid: Summary of Clinical Experience
Gerson, S. L., Kaplan, S. L., Bruss, J. B., Le, V., Arellano, F. M., Hafkin, B., & Kuter, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2723-2726.2002 · Cited by 443
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions
Shinabarger, D. L., Marotti, K. R., Murray, R. W., Lin, A. H., Melchior, E. P., Swaney, S. M., Dunyak, D. S., Demyan, W. F., & Buysse, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2132 · Cited by 384
Vancomycin Resistance in Staphylococci
Srinivasan, A., Dick, J. D., & Perl, T. M. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.3.430-438.2002 · Cited by 285
Thrombocytopenia Associated with Linezolid Therapy
Attassi, K., Hershberger, E., Alam, R., & Zervos, M. J. (2002) · Clinical Infectious Diseases · doi:10.1086/338403 · Cited by 259
Slatter, J. G., Stalker, D. J., Feenstra, K. L., Welshman, I. R., BRUSS, J. B., Sams, J. P., Johnson, M. G., Sanders, P., Hauer, M. J., Fagerness, P. E., et al. (2001) · PubMed · Cited by 248
Research works printed but not linked: 8
- 2002, MMWR Morb Mortal Wkly Rep, 51, 565
- Stalker DJ, 1997, DC: American Society for Microbiology, 23
- Stalker DJ, Wajszczuk CP, Batts DH. Linezolid safety, tolerance and pharmacokinetics following oral dosing twice daily for 14.5 days [abstract A115]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997:23.
- Wynalda MA, 2000, Drug Metab Dispos, 28, 1014
- Slatter JG, 2001, Drug Metab Dispos, 29, 1136
- Dresser LD, Birmingham MC, Karchmer AW, Rayner CR, Falvin SM, Schentag JJ. Results of treating infective endocarditis with linezolid [abstract 2239]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 2000:5.
- Zurenko GE, Todd WM, Hafkin B, etal Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid [abstract 848]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1997:118.
- Forrest A, Rayner CR, Meagher AK, Birmingham MC, Schentag JJ. Pharmacostatistical modelling of hematologic effects of linezolid (L) in seriously-ill patients (pts) [abstract 283]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 2000:5.
Cited by
Items 201–300 of 428
Treatment of Infections Caused by Resistant Staphylococcus aureus
Anstead, G. M., Quinones-Nazario, G., & Lewis, J. S. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-468-1_17 · Cited by 25
Minami, Y., Ishiko, S., Takai, Y., Kato, Y., Kagokawa, H., Takamiya, A., Nagaoka, T., Kinouchi, R., & Yoshida, A. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.075648 · Cited by 21
Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus
Pontefract, B., Rovelsky, S., & Madaras‐Kelly, K. (2020) · SAGE Open Medicine · doi:10.1177/2050312120970743 · Cited by 20
Takahashi, S., Tsuji, Y., Kasai, H., Ogami, C., Kawasuji, H., Yamamoto, Y., & To, H. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.02.014 · Cited by 19
Qi, C., Xu, S., Wu, M., Zhu, S., Liu, Y., Huang, H. D., Zhang, G., Li, J.-B., & Huang, X. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s219117 · Cited by 19
Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019*
Yavuz, S. Ş., Akar, A. R., Aydoğdu, S., Deniz, D. B., Demir, H., Hazırolan, T., Ozatik, M. A., Özer, N., Sargın, M., Topçuoğlu, N., et al. (2020) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2020.89689 · Cited by 25
Ding, L., Li, P. Z., Yang, Y., Lin, D., & Xu, X. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001234 · Cited by 19
Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics
Pong, A. L., & Bradley, J. S. (2004) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2004.01.005 · Cited by 20
Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria
Cobo, J., Lora-Tamayo, J., Euba, G., Jover-Sáenz, A., Palomino, J., del Toro, M., Rodríguez-Pardo, D., Riera, M., & Ariza, J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.019 · Cited by 19
de Feiter, P. W., Jacobs, J. A., Jacobs, M. J. H. M., Vink, C., & van der Geest, S. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021018 · Cited by 19
Peykov, S. Z., Kirov, B., & Strateva, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178207 · Cited by 21
Fang, E., Muñoz, K. A., & Prokocimer, P. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000534 · Cited by 18
Cho, Y., Lim, H., Cho, Y. L., Nam, H.-S., & Bae, K. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.10.007 · Cited by 18
Dejoies, L., Boukthir, S., de Ponfilly, G. P., Guen, R. L., Zouari, A., Potrel, S., Collet, A., Auger, G., Jacquier, H., Fihman, V., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa180 · Cited by 18
Nailor, M. D., & Sobel, J. D. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.03.011 · Cited by 20
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children
Tamma, P. D., & Hsu, A. J. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000115 · Cited by 18
Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents
Li, Y., Bionda, N., Fleeman, R. M., Wang, H., Ozawa, A., Houghten, R. A., & Shaw, L. N. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.027 · Cited by 21
Causal Relationship between Neuropathy and Prolonged Linezolid Use
Frippiat, F., & Derue, G. (2004) · Clinical Infectious Diseases · doi:10.1086/422147 · Cited by 18
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement
Berges‐Gimeno, M. P., Álvarez-Cuesta, E., Atanasković‐Marković, M., Attanasi, M., Caffarelli, C., Caubet, J., Toit, G. D., Guzman-Melendez, A., Kuyucu, S., Madrigal‐Burgaleta, R., et al. (2025) · World Allergy Organization Journal · doi:10.1016/j.waojou.2025.101087 · Cited by 22
Antimicrobial therapy for bone and joint infections
Aslam, S., & Darouiche, R. O. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-009-0002-x · Cited by 17
Broder, K. W., Moise, P. A., Schultz, R. O., Forrest, A., & Schentag, J. J. (2004) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000106888.60963.18 · Cited by 17
Self-citationInfective endocarditis treated with linezolid: case report and literature review
Hill, E. E., Herijgers, P., Herregods, M., & Peetermans, W. E. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0111-5 · Cited by 18
Inoue, Y., Takekuma, Y., Miyai, T., Kashiwagi, H., Sato, Y., Sugawara, M., & Imai, S. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03455-x · Cited by 16
Agashe, P., & Doshi, A. S. (2018) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2018.10.010 · Cited by 16
Ogami, C., Tsuji, Y., Nishi, Y., Kawasuji, H., To, H., & Yamamoto, Y. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000816 · Cited by 16
Reddy, P., Chadaga, S. R., & Noskin, G. A. (2009) · Journal of Hospital Medicine · doi:10.1002/jhm.505 · Cited by 19
Gallagher, R., Pizer, B. L., Ellison, J. A., & Riordan, F. A. I. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.06.023 · Cited by 16
Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis
Berdal, J., & Eskesen, A. N. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540802087209 · Cited by 15
Cho, Y., Lim, H., Han, S., Yoon, S. K., Kim, H., Cho, Y. L., Nam, H.-S., & Bae, K. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.11.009 · Cited by 15
Antimicrobial therapy ofStaphylococcus aureusbloodstream infection
Tacconelli, E., & Cataldo, M. A. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.15.2505 · Cited by 17
Li, J., Rayner, C. R., Dixson, S., & Nation, R. L. (2003) · Biomedical Chromatography · doi:10.1002/bmc.283 · Cited by 15
Self-citationLinezolid and Other Oxazolidinones
Cox, H. L., & Donowitz, G. R. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00032-1 · Cited by 17
Kaya, O., Akçam, F. Z., & Temel, E. N. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0801 · Cited by 14
Suleyman, G., & Zervos, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1127349 · Cited by 18
The management of chronic osteomyelitis
Marais, L., Ferreira, N., Aldous, C. R., & le Roux, T. (2014) · The South African Orthopaedic Journal (SAOJ) · Cited by 14
Brain Abscess Showing a Lack of Restricted Diffusion and Successfully Treated with Linezolid
Kim, J.-H., Park, S.-P., Moon, B. G., & Kim, D.-R. (2018) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2018.6.e16 · Cited by 14
Manfredi, R., Sabbatani, S., & Chiodo, F. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510036589 · Cited by 14
Linezolid Induced Reversible Peripheral Neuropathy
Vishnu, V. Y., Modi, M., Goyal, M., & Lal, V. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000359 · Cited by 14
Le linézolide, premier antibiotique de la famille des oxazolidinones
Dutronc, H., Bocquentin, F., Galpérine, T., Lafarie, S., & Dupon, M. (2005) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.09.006 · Cited by 16
Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin
Kohinke, R. M., & Pakyz, A. L. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0589-2 · Cited by 13
Li, K., Li, L., & Wang, J. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s423660 · Cited by 15
Patel, K., Kabir, R., Ahmad, S., & Allen, S. L. (2014) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155214556523 · Cited by 13
Bio, L. L., Perez, M. E., MacDougall, C., & Gallagher, J. C. (2011) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31822b7f6e · Cited by 13
Visual loss may be due to silicone oil tamponade effect rather than silicone oil removal
Rani, P. K., Raman, R., Bhende, P., & Sharma, T. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.082602 · Cited by 13
Visual loss following silicone oil removal
Newsom, R., Johnston, R., Sullivan, P., Aylward, B., Holder, G., & Gregor, Z. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.082644 · Cited by 13
Astigarraga, P. M. O., Garnacho‐Montero, J., Grau, S., Colomo, Ó. R., Palomar, M., Zaragoza, R., García-Paredes, P. M., Cerdá, E., & Lerma, F. Á. (2007) · Medicina Intensiva · doi:10.1016/s0210-5691(07)74829-5 · Cited by 12
Cai, Y., Chai, D., Falagas, M. E., Vouloumanou, E. K., Wang, R., Guo, D., Bai, N., Liang, B., & Liu, Y.-N. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2011.142 · Cited by 12
Current Evidence on Oral Antibiotics for Infective Endocarditis: A Narrative Review
Kobayashi, T., Ando, T., Streit, J. A., & Sekar, P. (2019) · Cardiology and Therapy · doi:10.1007/s40119-019-00148-4 · Cited by 12
Linezolid for infective endocarditis: A structured approach based on a national database experience
Muñóz, P., de la Villa, S., Martínez‐Sellés, M., Goenaga, M. Á., Reviejo, K., Revillas, F. A. D. L., García-Cuello, L., Hidalgo-Tenorio, C., Esteban, Á. R., Antorrena, I., et al. (2021) · Medicine · doi:10.1097/md.0000000000027597 · Cited by 12
Subramanian, P. S., Miller, N. R., Renard, V., & Tamargo, R. J. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.078626 · Cited by 12
Scleral contact lenses are not optically inferior to corneal lenses
Salam, A., Melia, B., & Singh, A. J. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.074377 · Cited by 12
Probable Linezolid‐Induced Pancytopenia
Lakhani, N., Thompson, W., & Bombassaro, A. M. (2004) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2005/961613 · Cited by 12
Goldim, J. R. (2008) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892008000300007 · Cited by 12
Role of linezolid in the treatment of orthopedic infections
Bassetti, M., Righi, E., Biagio, A. D., Rosso, R., Beltrame, A., & Bassetti, D. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.3.343 · Cited by 12
Compassionate Use of Linezolid for Adult Taiwanese Patients with Bone and Joint Infections
Lu, P., Wang, J., Chen, C., Chen, W., Chen, T., Hwang, Y.-C., & Chang, S. (2010) · Chemotherapy · doi:10.1159/000317752 · Cited by 11
Linezolid‐induced purpuric medication reaction
Kim, F. S., Kelley, W., Resh, B., & Goldenberg, G. (2009) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2008.01103.x · Cited by 11
Kim, Y., Kim, A., Lee, S., Choi, S.-H., Lee, D., Song, J.-S., Lee, H., Jang, I., & Yu, K. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.08.002 · Cited by 11
ENTEROCOCCAL AND VIRIDANS STREPTOCOCCAL INFECTIONS
English, B. K., & Shenep, J. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50100-x · Cited by 12
Nutritional and Toxic Optic Neuropathies
Wang, M. Y., Sadun, A. A., & Chan, J. W. (2014) · Springer eBooks · doi:10.1007/978-1-4614-0691-4_6 · Cited by 10
Linezolid Desensitization for a Patient with Multiple Medication Hypersensitivity Reactions
Bagwell, A., Stollings, J. L., White, K. D., Fadugba, O. O., & Choi, J. J. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1s033 · Cited by 10
Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report
Xiao, B., Deng, P., Jin, H., Wang, H., & Cao, Y. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.911362 · Cited by 10
Yavuz, S. Ş., Akar, A., Aydoğdu, S., Berzeg-Deniz, D., Demir, H., Hazırolan, T., Özatık, M. A., Özer, N., Sarğın, M., Topçuoğlu, N., et al. (2020) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2020.01954 · Cited by 13
Wielgus, E., Paluch, P., Frelek, J., Szczepek, W. J., & Potrzebowski, M. J. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24606 · Cited by 10
Linezolid versus Vancomycin for Prosthetic Joint Infections: a Cost Analysis
You, J. H. S., Lee, G. C., So, R., Cheung, K. W., & Hui, M. (2007) · Infection · doi:10.1007/s15010-007-6304-8 · Cited by 10
Wang, M.-G., Wang, D., & He, J. (2018) · Medicine · doi:10.1097/md.0000000000011997 · Cited by 10
Neuropathie optique toxique grave liée au linézolide
Xerri, O., Lemaire, B., Nasser, G., Rousseau-Huvey, B., Labétoulle, M., & Rousseau, A. (2015) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2014.05.020 · Cited by 10
Use of linezolid in children: an overview of recent advances
Velissariou, I. M. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.6.947 · Cited by 10
Chow, F. C., Kafeero, P., Nakimbugwe, M., Ssemaganda, A., Tayebwa, C., Farrell, E., Wilson, M., Nahid, P., Savić, R. M., Cresswell, F. V., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf089 · Cited by 9
Tsuji, Y. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00002 · Cited by 9
Guang, Y., Yan, Y., Mao, J., Liu, H., Chen, M., Zhang, N., Li, Y., Gu, J., & Huang, X. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s343200 · Cited by 9
Zhou, Z.-Y., Zhao, X.-Q., Shan, B., Zhu, J., Zhang, X., Tian, Q., Chen, D., & Jia, T. (2013) · Indian Journal of Microbiology · doi:10.1007/s12088-013-0422-z · Cited by 9
McLaughlin, M. M., Malczynski, M., Qi, C., Barajas, G., Radetski, J., Zembower, T., & Scheetz, M. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00192-13 · Cited by 11
Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Intraabdominelle Infektionen
Eckmann, C., Isenmann, R., Kujath, P., Pross, A., Rodloff, A. C., & Schmitz, F. (2020) · GMS infectious diseases · doi:10.3205/id000057 · Cited by 13
Scheetz, M. H., Qi, C., Noskin, G. A., Warren, J. R., Postelnick, M. J., Malczynski, M., Huang, J., & Zembower, T. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.06.018 · Cited by 9
Vlase, L., Muntean, D. M., Cuciureanu, M. D., Cuciureanu, R., & Gocan, S. (2011) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2011.555677 · Cited by 9
Chi, C., Lauderdale, T.-L. Y., Wang, S.-M., Wu, J.-M., Yang, Y.-J., & Liu, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01004-07 · Cited by 9
Haematological safety of long-term therapy with linezolid
Garazzino, S., Rosa, F. G. D., Bargiacchi, O., Audagnotto, S., Maiello, A., & Perri, G. D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.12.007 · Cited by 9
Collège de Bactériologie Virologie Hygiène Study Group (ColBVH), Gallon, O., Guillet-Caruba, C., Lamy, B., Laurent, F. J., Doucet‐Populaire, F., & Decousser, J. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0764-y · Cited by 9
Linezolid induced toxic optic neuropathy in drug resistant tuberculosis-A case series
Vallabhaneni, S., Mendonca, T. M., Nayak, R. R., Kamath, G. M., & Kamath, A. R. (2023) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2023.06.016 · Cited by 8
Wang, D., Ikemura, K., Hasegawa, T., Yamane, F., & Okuda, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116801 · Cited by 8
Synthesis and antibacterial activities of baulamycin A inspired derivatives
Kim, N., Sengupta, S., Lee, J., Dash, U., Kim, S., Kim, H. J., Song, C., & Sim, T. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115592 · Cited by 8
Deng, J., Su, L., Liang, Z.-X., Liang, L.-L., Yan, P., Jia, Y., Zhang, X., Feng, D., & Xie, L. (2013) · Current Therapeutic Research · doi:10.1016/j.curtheres.2012.12.002 · Cited by 8
Filsner, P. H. D. L. N., de Almeida, L. M., Moreno, M., Moreno, L. Z., Matajira, C. E. C., da Silva, K. C., Pires, C., Cerdeira, L., Sacramento, A. G., Mamizuka, E. M., et al. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.02.002 · Cited by 8
Fermeli, D. D., Marantos, T., Liarakos, A. L., Panayiotakopoulos, G. D., Dedes, V., & Panoutsopoulos, G. I. (2020) · Folia Medica · doi:10.3897/folmed.62.e48742 · Cited by 9
Gutierrez, K. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00078-7 · Cited by 10
Jasovich, A., Ganaha, M. C., Ebi, C., García, R., Blanco, M. Á. R., & Lopardo, H. Á. (2008) · PubMed · Cited by 10
FDG PET Assessment of Osteomyelitis: A Review
Dioguardi, P., Gaddam, S. R., Zhuang, H., Torigian, D. A., & Alavi, A. A. (2012) · PET Clinics · doi:10.1016/j.cpet.2012.01.011 · Cited by 8
O'Connor, C., Casserly, L. F., Qazi, J., Power, L., Finnegan, C., O’Connell, N. H., & Dunne, C. P. (2015) · JMM Case Reports · doi:10.1099/jmmcr.0.000089 · Cited by 8
A Rare Skin Rash: Linezolid-Induced Purpuric Drug Eruption without Vasculitis in a Puerto Rican Man
Tirú-Vega, M., Engel-Rodriguez, N., Rivera-Bobe, N., & Cruz‐Diaz, C. N. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.941725 · Cited by 7
Patel, A. S., Doernberg, S. B., Zack, T. I., Butte, A. J., & Radtke, K. K. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3201 · Cited by 7
Linezolid induced optic neuropathy, a serious yet reversible adverse effect: a case report
Shah, R. K., & Lamichhane, S. (2017) · European Journal of Medical Case Reports · doi:10.24911/ejmcr/1/28 · Cited by 7
Linezolid-induced pancytopenia
Leader, R., Hackett, J., Allan, A., & Carter, P. M. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225480 · Cited by 7
Vu, M., Smith, K. J., Aspinall, S. L., Clancy, C. J., & Buehrle, D. J. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01077-8 · Cited by 8
Vlase, L., Muntean, D. M., Cuciureanu, M. D., Cuciureanu, R., & Gocan, S. (2011) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2010.535480 · Cited by 7
Bassetti, M., Almirante, B., Giamarellos‐Bourboulis, E. J., Gournellis, R., Grande, I., Marini, M. G., & Balestrieri, M. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000637 · Cited by 8
Astigarraga, P. M. O., Garnacho‐Montero, J., Grau, S., Colomo, Ó. R., Palomar, M., Zaragoza, R., García-Paredes, P. M., Cerdá, E., & Lerma, F. Á. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13108709 · Cited by 9
Huang, S.-T., Yang, J.-L., Lin, C., Huang, S., Wang, J., Chuang, Y., Chen, Y., & Chang, S. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.01.035 · Cited by 6
Vancomycin-Resistant Enterococcus in Critical Care Areas
Bryant, S. E., & Wilbeck, J. (2007) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2006.10.005 · Cited by 6
Colistin-related thrombocytopenia
Küpeli, S. (2015) · Platelets · doi:10.3109/09537104.2015.1004044 · Cited by 6
Treatment Strategies to Combat Multidrug Resistance (MDR) in Bacteria
Jan, B., Jan, R., Afzal, S., Ayoub, M., & Masoodi, M. H. (2023) · Springer eBooks · doi:10.1007/978-981-19-9167-7_4 · Cited by 6
Metadata
- Authors
- Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J.
- Affiliations
- University at Buffalo, State University of New York (US)
- Kalamazoo Public Library (US)
- Corresponding author
- Schentag, Jerome J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-15
- Volume
- 36
- Issue
- 2
- Pages
- 159-168
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2153039659
- Semantic Scholar
- 884899ebe7caae27908d4715f8dc57cf1db6c0c1
- Cited by
- 428
- References
- 25
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 8 · 2023: 14 · 2022: 7 · 2021: 9 · 2020: 18 · 2019: 12 · 2018: 17 · 2017: 14 · 2016: 13 · 2015: 21 · 2014: 19 · 2013: 19 · 2012: 13
- FWCI
- 21.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- linezolid, compassionate use program, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, bacteremia, endocarditis, osteomyelitis, complicated skin and skin structure infections, intra-abdominal infection, clinical cure, adverse events, drug tolerability
- MeSH terms
- Linezolid, Acetamides, Adolescent, Adult, Aged, Anti-Infective Agents, Drug Interactions, Female, Humans, Male, Middle Aged, Treatment Outcome, Gram-Positive Bacterial Infections, Drug Resistance, Multiple, Oxazolidinones, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.